Viewing Study NCT01780259


Ignite Creation Date: 2025-12-24 @ 2:59 PM
Ignite Modification Date: 2025-12-25 @ 5:44 PM
Study NCT ID: NCT01780259
Status: COMPLETED
Last Update Posted: 2013-08-09
First Post: 2013-01-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module